Lalitha Ramanna
About
In The Last Decade
Lalitha Ramanna
35 papers receiving 686 citations
Peers
Comparison fields: 5 of 65
- Pulmonary and Respiratory Medicine 307
- Radiology, Nuclear Medicine and Imaging 302
- Surgery 216
- Endocrinology, Diabetes and Metabolism 200
- Pathology and Forensic Medicine 73
Countries citing papers authored by Lalitha Ramanna
This map shows the geographic impact of Lalitha Ramanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalitha Ramanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalitha Ramanna more than expected).
Fields of papers citing papers by Lalitha Ramanna
This network shows the impact of papers produced by Lalitha Ramanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalitha Ramanna. The network helps show where Lalitha Ramanna may publish in the future.
Co-authorship network of co-authors of Lalitha Ramanna
This figure shows the co-authorship network connecting the top 25 collaborators of Lalitha Ramanna. A scholar is included among the top collaborators of Lalitha Ramanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalitha Ramanna. Lalitha Ramanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 24 | |
| 3 | Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma. | 37 |
| 4 | Transient radiation effects following high dose I-131 therapy for differentiated thyroid cancer (DTC) | 3 |
| 5 | Thallium scintigraphy in the evaluation of mass abnormalities of the breast. | 80 |
| 6 | 1 | |
| 7 | 1 | |
| 8 | Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. | 40 |
| 9 | Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. | 95 |
| 10 | 42 | |
| 11 | 32 | |
| 12 | 2 | |
| 13 | 67 | |
| 14 | 58 | |
| 15 | 28 | |
| 16 | 3 | |
| 17 | The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication. | 72 |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.